Nanoemulsions for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (10 July 2022) | Viewed by 595
Special Issue Editor
Special Issue Information
Dear Colleagues,
I am pleased to invite you to contribute to this Special Issue intended to present recent developments in nanoemulsion formulations and technologies for drug delivery. Nanoemulsions are soft tunable and versatile nanosystems presenting numerous possibilities for drug encapsulation and targeting. Among innovative lipidic nanosystems, nanoemulsions provide advantageous properties for drug delivery, including the possible use of FDA-approved excipients, the high encapsulation capacity for both hydrophobic drugs and for hydrophilic drugs in multiple nanoemulsions. For the encapsulated drug, the nanoemulsion systems improve bioavailability and stability thanks to the resistance they provide against hydrolysis and oxidation after administration. Due to the soft material and the nanometric scale of the droplets, nanoemulsions may be administered through a very broad variety of general administration routes, including oral, parenteral, nasal, and transdermal; they can also be delivered locally (e.g., ophthalmic, dermal, pulmonary), which greatly broadens their potential therapeutic applications. These applications include vaccination, cancer therapy, neurodegenerative diseases, and therapeutic oxygen delivery. However, as metastable systems, research on improving their stability in formulations (e.g., phase gelification or rigidified droplet interfaces) and on engineering methods (i.e., improving high- or low-energy emulsification processes) is essential for their development in therapeutics. This Special Issue aims to highlight the recent progress in nanoemulsions-based therapy, helping to take it from the bench to the bedside.
I look forward to receiving your contributions.
Prof. Dr. Sylvie Crauste-Manciet
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoemulsions
- multiple nanoemulsions
- self-emulsification
- drug carrier
- drug targeting
- nanocapsule
- nanoemulgel
- nanobubble
- nanomedicine
- therapeutics
- pharmaceutics
